SCHEMBL22858313

SCHEMBL22858313

Nc1cnn2ccc(C(F)(F)F)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
PKM P14618 1/20 0.45
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
CDC7 O00311 1/20 0.38
CDK2 P24941 1/20 0.38
SCN5A Q14524 1/20 0.38
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
CA2 P00918 1/20 0.36
KDM4E B2RXH2 4/20 0.35
PIK3CA P42336 1/20 0.35
SMPD3 Q9NY59 2/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
USP7 Q93009 1/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17323995 0.79 PIK3CA (0.42) ALDH1A1PKMSCN5ACA2KDM4E
SCHEMBL31383583 0.79 SCN5A (0.38) ALDH1A1PKMCDC7CDK2SCN5A
SCHEMBL28550637 0.79 SCN5A (0.38) ALDH1A1PKMCDC7CDK2SCN5A
SCHEMBL15898895 0.76 PSEN1 (0.41) ALDH1A1PKMSCN5ACA2KDM4E
SCHEMBL16629843 0.76 PSEN1 (0.45) ALDH1A1SCN5ACA2KDM4EPIK3CA
SCHEMBL25099097 0.76 MAT2A (0.40) ALDH1A1PKMSCN5ACA2KDM4E
SCHEMBL3089803 0.76 PSEN1 (0.41) ALDH1A1PKMSCN5ACA2KDM4E
SCHEMBL3070883 0.76 PIK3CA (0.44) ALDH1A1PKMSCN5ACA2KDM4E
SCHEMBL24369209 0.74 ALDH1A1 (0.44) ALDH1A1PKMKDM4EHPGDNPC1
SCHEMBL31204862 0.73 ACSS2 (0.34) SCN5ASMPD3CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021000957-A1 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 北京国鸿生物医药科技有限公司 2021-01-07 WO disclosed